Physician profile
Mark Stuart Bailey
NPI 1336368661
$3,196.26
in general payments reported to CMS, 2019-2025
17 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,042 · 2020: $149 · 2021: $455 · 2022: $117 · 2023: $391 · 2024: $757 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Education: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.92 |
| Education | $434.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,046.87 | 2019-2024 | Comprehensive Shoulder System, Persona, Avitus Bone Harvester |
| Kci USA, INC. | $818.55 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Horizon Therapeutics Plc | $298.34 | 2019-2022 | |
| Stryker Corporation | $222.01 | 2025 | Gamma, Iris, 1688 |
| Djo, LLC | $198.09 | 2021-2025 | Cmf |
| Radius Health, INC. | $190.70 | 2019-2024 | Tymlos |
| Bioventus LLC | $64.68 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $64.55 | 2024 | Zynrelef |
| Smith+Nephew, INC. | $60.77 | 2019-2024 | Stravix |
| Innovation Technologies INC | $57.70 | 2023-2024 | Irrisept |
| Acera Surgical, INC. | $47.83 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $46.24 | 2022-2023 | Iovera |
| Polynovo North America LLC | $18.46 | 2024 | Novosorb Btm |
| Globus Medical, INC. | $18.18 | 2025 | Omnia |
| Baudax Bio INC. | $17.22 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthalign INC | $14.09 | 2024 | Orthalign Plus |
| Kerecis Limited | $11.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.